Telos Rx vs bmiMD: Compounded GLP-1 Options Compared

Quick verdict: For lower advertised starting prices on semaglutide and a choice of semaglutide or tirzepatide, Telos Rx may suit people seeking as low as $99 per month and pay $0 if not approved; for tiered tirzepatide pricing with free shipping and 24/7 clinician access, bmiMD may suit people willing to commit to longer plans to reach $139 per month.

See Telos Rx pricing and eligibility

Telos Rx vs bmiMD: overview of the services

This comparison of Telos Rx vs bmiMD focuses on the facts each provider publishes: Telos Rx offers compounded semaglutide and tirzepatide prescribed online starting at $99 and $139 per month respectively when a US-licensed provider approves you, with statements that you pay $0 if not approved; bmiMD offers compounded tirzepatide with four billing options and month-to-month pricing starting at $179 and a 12-month option that brings the monthly equivalent to $139, plus free shipping and 24/7 clinician access. Both state that treatment is available only when a licensed clinician decides it is medically appropriate and that compounded medications are not FDA-approved.

Key differences: price structure, medication selection, clinician access

The most distinctive differences between Telos Rx and bmiMD are pricing and billing options, whether semaglutide is offered, and the advertised clinical access and shipping terms. Below we compare these points directly using only the supplied evidence.

1. Price model and starting price

Telos Rx advertises semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with a note that you pay $0 if not approved. Telos Rx also lists higher reference figures such as $299 and $399 paired with the lower monthly amounts in its materials and says your price depends on your plan. bmiMD lists tirzepatide at $179 month-to-month, with lower per-month equivalents if you select 3, 6, or 12 month plans down to $139 per month for a 12-month commitment.

2. Medication options offered

Telos Rx offers both semaglutide and tirzepatide, explicitly noting semaglutide acts on GLP-1 while tirzepatide acts on GLP-1 and GIP and that a US-licensed provider decides which is right for you. bmiMD evidence covers compounded tirzepatide only in the captured materials. If access to semaglutide specifically matters, that distinction is supported by the source content.

3. Shipping, clinician access, and plan commitments

bmiMD advertises free subscription shipping on every subscription order and 24/7 clinician access, and it highlights four billing options where the lowest monthly price requires a longer commitment. Telos Rx materials emphasize clinician review by a US-licensed provider, say cancel anytime with no penalties in some descriptions, and include the pay $0 if not approved qualifier. Both sources repeat the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

Comparison table: direct side-by-side facts

How approval, refunds, and commitments compare

Telos Rx states that semaglutide and tirzepatide are prescription-only and subject to medical approval by a US-licensed provider and that you may pay $0 if not approved. bmiMD states its program is 100% refundable if not eligible for the program and that the lowest per-month price requires a 12-month commitment, with total prepaid charges to be confirmed. Both providers warn that compounded medications are not FDA-approved and eligibility, state availability, and renewal terms should be confirmed before enrollment.

View bmiMD tirzepatide billing options

Safety and regulatory notes

Both sources explicitly state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both say treatment is available only when a licensed clinician determines it is medically appropriate. Beyond those statements, no other safety outcomes or clinical efficacy claims are supplied in the captured evidence and are not asserted here.

Check Telos Rx clinician review details

Bottom line and who should choose which provider

Telos Rx vs bmiMD breaks down to a choice between lower advertised starting prices and two medication options at Telos Rx versus tiered billing, free shipping, and 24/7 clinician access at bmiMD for tirzepatide. Both require clinician review and both offer compounded medications that are not FDA-approved. Confirm eligibility, state availability, total cost and renewal terms with each before enrolling.

Compare Telos Rx plans now

Compare bmiMD subscription lengths

Choose Telos Rx if…

You want access to both compounded semaglutide and tirzepatide with advertised semaglutide pricing as low as $99 per month and a clinician will decide whether you are approved, with materials that state you pay $0 if not approved and that you can cancel anytime under described terms.

Choose bmiMD if…

You are focused on compounded tirzepatide with free subscription shipping, 24/7 clinician access, and you are willing to consider longer billing commitments to reach the advertised $139 per month 12-month equivalent. Both providers require clinician review and note that compounded medications are not FDA-approved.